Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,973
archived clinical trials in
High Cholesterol

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling
Updated:  1/11/2016
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling
Updated: 1/11/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling
Updated:  1/11/2016
509
mi
from
Graz,
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Status: Enrolling
Updated: 1/11/2016
509
mi
from
Graz,
Click here to add this to my saved trials
Genetic Influence on Statin Pharmacodynamics
An Observational Study Investigating Genetic Influences on Clinical Outcomes and Change in Carotid Intimal Thickness in Adults Taking Atorvastatin, Simvastatin, or Lovastatin
Status: Enrolling
Updated:  1/15/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Genetic Influence on Statin Pharmacodynamics
An Observational Study Investigating Genetic Influences on Clinical Outcomes and Change in Carotid Intimal Thickness in Adults Taking Atorvastatin, Simvastatin, or Lovastatin
Status: Enrolling
Updated: 1/15/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Improving Adherence to Statins Among Minority Populations
Improving Adherence to Cholesterol Lowering Medications Among Minority Populations in Florida: A Randomized Trial
Status: Enrolling
Updated:  1/21/2016
University of Miami
mi
from
Miami, FL
Improving Adherence to Statins Among Minority Populations
Improving Adherence to Cholesterol Lowering Medications Among Minority Populations in Florida: A Randomized Trial
Status: Enrolling
Updated: 1/21/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
Status: Enrolling
Updated:  1/28/2016
CTRC (Clinical Translational Research Center)
mi
from
Philadelphia, PA
Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
Status: Enrolling
Updated: 1/28/2016
CTRC (Clinical Translational Research Center)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effects of Acipimox on Mitochondrial Function in Obesity
The Effects of Short Term Acipimox Treatment on Skeletal Muscle Phosphocreatine Recovery in Obesity
Status: Enrolling
Updated:  2/2/2016
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Acipimox on Mitochondrial Function in Obesity
The Effects of Short Term Acipimox Treatment on Skeletal Muscle Phosphocreatine Recovery in Obesity
Status: Enrolling
Updated: 2/2/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism
Postprandial Modulation of HDL Metabolism
Status: Enrolling
Updated:  2/3/2016
UC Davis, Ragle Human Nutrition Center
mi
from
Davis, CA
Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism
Postprandial Modulation of HDL Metabolism
Status: Enrolling
Updated: 2/3/2016
UC Davis, Ragle Human Nutrition Center
mi
from
Davis, CA
Click here to add this to my saved trials
Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia
Effects of Lovaza Monotherapy vs. Placebo on Composition and Function of HDL and Other Lipoproteins, and on Other Lipid-Related Parameters
Status: Enrolling
Updated:  2/4/2016
University of Utah
mi
from
Salt Lake City, UT
Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia
Effects of Lovaza Monotherapy vs. Placebo on Composition and Function of HDL and Other Lipoproteins, and on Other Lipid-Related Parameters
Status: Enrolling
Updated: 2/4/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors
Status: Enrolling
Updated:  2/4/2016
Cardiovascular Genetics, University of Utah
mi
from
Salt Lake City, UT
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors
Status: Enrolling
Updated: 2/4/2016
Cardiovascular Genetics, University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects
Status: Enrolling
Updated:  2/11/2016
Clinical Research Facility
mi
from
Glendale, CA
Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects
Status: Enrolling
Updated: 2/11/2016
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312
Status: Enrolling
Updated:  2/16/2016
Clinical Research Facility
mi
from
Madison, WI
Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312
Status: Enrolling
Updated: 2/16/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
The Health Outcomes Management and Evaluation (HOME) Study
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated:  2/25/2016
Cobb County Community Service Board
mi
from
Marietta, GA
The Health Outcomes Management and Evaluation (HOME) Study
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated: 2/25/2016
Cobb County Community Service Board
mi
from
Marietta, GA
Click here to add this to my saved trials
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Status: Enrolling
Updated:  2/25/2016
Baylor College of Medicine
mi
from
Houston, TX
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Status: Enrolling
Updated: 2/25/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children's Hopsital of Los Angeles
mi
from
Los Angeles, CA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children's Hopsital of Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of California, San Diego
mi
from
San Diego, CA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Childrens National Medical Center
mi
from
Washington,
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children'S Diagnostic Treatment Center
mi
from
Fort Lauderdale, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children'S Diagnostic Treatment Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of Miami
mi
from
Miami, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of South Florida
mi
from
Tampa, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Stoger Hospital of Cook County
mi
from
Chicago, IL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Stoger Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Tulane University
mi
from
New Orleans, LA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Montefiore Medical Center
mi
from
Bronx, NY
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Mt. Sinai Hospital
mi
from
New York City, NY
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Mt. Sinai Hospital
mi
from
New York City, NY
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Cypress, CA
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Stanford, CA
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Boston, MA
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Durham, NC
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  3/1/2016
Clinical Research Facility
mi
from
Nashville, TN
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/1/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
Univ. of Colorado Denver NICHD CRS (5052)
mi
from
Aurora, CO
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
Univ. of Colorado Denver NICHD CRS (5052)
mi
from
Aurora, CO
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
Univ. of Miami Ped. Perinatal HIV/AIDS CRS (4201)
mi
from
Miami, FL
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
Univ. of Miami Ped. Perinatal HIV/AIDS CRS (4201)
mi
from
Miami, FL
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
University of South Florida Tampa (5018)
mi
from
Tampa, FL
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
University of South Florida Tampa (5018)
mi
from
Tampa, FL
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
Chicago Children's CRS (4001)
mi
from
Chicago, IL
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
Chicago Children's CRS (4001)
mi
from
Chicago, IL
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
Tulane University (5095)
mi
from
New Orleans, LA
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
Tulane University (5095)
mi
from
New Orleans, LA
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
Boston Medical Center Ped. HIV Program NICHD CRS (5011)
mi
from
Boston, MA
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
Boston Medical Center Ped. HIV Program NICHD CRS (5011)
mi
from
Boston, MA
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
Bronx-Lebanon Hospital IMPAACT CRS (6901)
mi
from
Bronx, NY
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
Bronx-Lebanon Hospital IMPAACT CRS (6901)
mi
from
Bronx, NY
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
Metropolitan Hospital (5003)
mi
from
New York, NY
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
Metropolitan Hospital (5003)
mi
from
New York, NY
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
New York University NY (5012)
mi
from
New York, NY
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
New York University NY (5012)
mi
from
New York, NY
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
St. Jude/UTHSC CRS (6501)
mi
from
Memphis, TN
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
St. Jude/UTHSC CRS (6501)
mi
from
Memphis, TN
Click here to add this to my saved trials
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated:  3/8/2016
Texas Children's Hosp. CRS (3801)
mi
from
Houston, TX
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Status: Enrolling
Updated: 3/8/2016
Texas Children's Hosp. CRS (3801)
mi
from
Houston, TX
Click here to add this to my saved trials
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated:  3/10/2016
Robert's Discount Pharmacy
mi
from
Hoover, AL
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated: 3/10/2016
Robert's Discount Pharmacy
mi
from
Hoover, AL
Click here to add this to my saved trials
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated:  3/10/2016
Pharmacy at the Pig
mi
from
McCalla, AL
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated: 3/10/2016
Pharmacy at the Pig
mi
from
McCalla, AL
Click here to add this to my saved trials
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated:  3/10/2016
Pinson Discount Drugs
mi
from
Pinson, AL
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated: 3/10/2016
Pinson Discount Drugs
mi
from
Pinson, AL
Click here to add this to my saved trials
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated:  3/10/2016
Community Clinical Pharmacy
mi
from
Mesa, AZ
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated: 3/10/2016
Community Clinical Pharmacy
mi
from
Mesa, AZ
Click here to add this to my saved trials
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated:  3/10/2016
Melrose Pharmacy
mi
from
Phoenix, AZ
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated: 3/10/2016
Melrose Pharmacy
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated:  3/10/2016
Parkview Compounding Pharmacy
mi
from
Rancho Cucamonga, CA
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated: 3/10/2016
Parkview Compounding Pharmacy
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated:  3/10/2016
Garden Drug
mi
from
Fort Lauderdale, FL
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated: 3/10/2016
Garden Drug
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated:  3/10/2016
Pill Box Pharmacy and Medical Supply
mi
from
Pembroke Pines, FL
Actual Use Trial of Atorvastatin Calcium 10 mg
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Status: Enrolling
Updated: 3/10/2016
Pill Box Pharmacy and Medical Supply
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials